transferrin has been researched along with Dyslipidemia in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bruzoni, M; Dewberry, LC; Inge, TH; Jenkins, TM; Kelsey, M; Ogle, SB; Pratt, JSA | 1 |
| Chen, Y; He, B; Xiao, Y; Zhu, Y | 1 |
| Fernandes, D; Frommer, DJ; Goud, R; Pawar, G | 1 |
| Chaudhari, AS; Kumar, GN; Raghuvanshi, R | 1 |
| Armstrong, VW; Bramlage, CP; Bramlage, P; Koziolek, MJ; Mueller, GA; Zapf, A | 1 |
| Arneth, B; Bornstein, SR; Fischer, S; Julius, U; Schatz, U; Siegels, D; Siegert, G | 1 |
| Belaia, OL; Ivanova, LA; Kalmykova, VI; Kochergina, LG | 1 |
| Baĭder, LM; Belaia, OL; Fomina, IG; Kuropteva, ZV; Tiukavkina, NA | 1 |
3 trial(s) available for transferrin and Dyslipidemia
| Article | Year |
|---|---|
Low-density lipoprotein apheresis decreases ferritin, transferrin and vitamin B12, which may cause anemia in serially treated patients.
Topics: Anemia; Blood Component Removal; Dyslipidemias; Erythropoiesis; Female; Ferritins; Filtration; Heparin; Humans; Hyperlipoproteinemia Type II; Lipoprotein(a); Lipoproteins, LDL; Male; Middle Aged; Plasmapheresis; Transferrin; Vitamin B 12 | 2010 |
Iron deficiency and its management in patients undergoing lipoprotein apheresis. Comparison of two parenteral iron formulations.
Topics: Aged; Anemia, Iron-Deficiency; Biomarkers; Blood Component Removal; Chemistry, Pharmaceutical; Drug Administration Schedule; Dyslipidemias; Female; Ferric Compounds; Ferritins; Germany; Hematinics; Humans; Infusions, Intravenous; Lipoproteins; Male; Maltose; Middle Aged; Time Factors; Transferrin; Treatment Outcome | 2013 |
[Experience in coenzyme Q10 application in complex therapy of coronary heart disease with dyslipidemia].
Topics: Ceruloplasmin; Coenzymes; Coronary Disease; Drug Therapy, Combination; Dyslipidemias; Female; Humans; Hypolipidemic Agents; Lipid Peroxidation; Male; Middle Aged; Simvastatin; Transferrin; Ubiquinone | 2006 |
5 other study(ies) available for transferrin and Dyslipidemia
| Article | Year |
|---|---|
Outcomes of Bariatric Surgery in Older Versus Younger Adolescents.
Topics: Adolescent; Age Factors; Bariatric Surgery; Body Mass Index; Comorbidity; Diabetes Mellitus, Type 2; Dyslipidemias; Female; Humans; Hypertension; Male; Nutrition Disorders; Obesity, Morbid; Pediatric Obesity; Prevalence; Prospective Studies; Quality of Life; Remission Induction; Time Factors; Transferrin; Treatment Outcome; United States; Vitamin D Deficiency; Weight Loss; Young Adult | 2021 |
Iron metabolism and its association with dyslipidemia risk in children and adolescents: a cross-sectional study.
Topics: Adolescent; Anemia, Iron-Deficiency; Anthropometry; Body Mass Index; Child; Cholesterol, HDL; Cholesterol, LDL; Cross-Sectional Studies; Diet; Dyslipidemias; Exercise; Female; Ferritins; Humans; Iron; Male; Receptors, Transferrin; Surveys and Questionnaires; Transferrin; Triglycerides | 2019 |
Gastrointestinal amyloidosis in Australian indigenous patients.
Topics: Abdominal Pain; Adult; Aged; Aged, 80 and over; Amyloidosis; Bacterial Infections; C-Reactive Protein; Candidiasis; Cardiovascular Diseases; Comorbidity; Deltaretrovirus Infections; Diabetes Mellitus, Type 2; Diarrhea; Dyslipidemias; Female; Ferritins; Gastrointestinal Diseases; Gastrointestinal Hemorrhage; Humans; Hypoalbuminemia; Male; Middle Aged; Native Hawaiian or Other Pacific Islander; Northern Territory; Prognosis; Renal Insufficiency, Chronic; Serum Amyloid A Protein; Transferrin; Vomiting | 2014 |
Genetically engineered Escherichia coli Nissle 1917 synbiotic counters fructose-induced metabolic syndrome and iron deficiency.
Topics: Animals; Body Weight; Diet; Dyslipidemias; Escherichia coli; Fructose; Genetic Engineering; Hyperglycemia; Iron; Iron Deficiencies; Liver; Mannitol Dehydrogenases; Metabolic Syndrome; Oxidative Stress; PQQ Cofactor; Probiotics; Rats; Synbiotics; Transferrin | 2017 |
[The influence of the bioflanoid dicvertin on the antioxidative system ceruloplasmin-transferrin and lipid peroxidation in patients suffering from stable coronary heart disease with dyslipidemia].
Topics: Antioxidants; Ceruloplasmin; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Dyslipidemias; Female; Flavanones; Follow-Up Studies; Humans; Lipid Peroxidation; Male; Middle Aged; Oxidative Stress; Transferrin; Treatment Outcome | 2006 |